| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia
|
de Lavallade, Hugues
|
|
2010
|
34 |
2 |
p. 254-257
4 p.
|
artikel
|
| 2 |
An open-label, Phase I study of cediranib (RECENTIN™) in patients with acute myeloid leukemia
|
Fiedler, Walter
|
|
2010
|
34 |
2 |
p. 196-202
7 p.
|
artikel
|
| 3 |
A novel MLL-AF1p/Eps15 fusion variant in therapy-related acute lymphoblastic leukemia, lacking the EH-domains
|
Shinohara, Akihito
|
|
2010
|
34 |
2 |
p. e62-e63
nvt p.
|
artikel
|
| 4 |
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia
|
Yokohama, Akihiko
|
|
2010
|
34 |
2 |
p. 203-209
7 p.
|
artikel
|
| 5 |
BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients
|
Moon, Joon Ho
|
|
2010
|
34 |
2 |
p. 166-172
7 p.
|
artikel
|
| 6 |
BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant
|
Salomon, Ophira
|
|
2010
|
34 |
2 |
p. e78-e81
nvt p.
|
artikel
|
| 7 |
2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma
|
Orciuolo, Enrico
|
|
2010
|
34 |
2 |
p. 184-189
6 p.
|
artikel
|
| 8 |
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia
|
Bruey, Jean-Marie
|
|
2010
|
34 |
2 |
p. 173-176
4 p.
|
artikel
|
| 9 |
Clarification on the categorization of comorbidities
|
Wang, Rong
|
|
2010
|
34 |
2 |
p. e74-
1 p.
|
artikel
|
| 10 |
Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: A case report and discussion in the context of similar cases
|
McClure, Rebecca
|
|
2010
|
34 |
2 |
p. e71-e73
nvt p.
|
artikel
|
| 11 |
Complications of chronic lymphocytic leukemia: Analysis of 203 cases in China
|
Wu, Tong
|
|
2010
|
34 |
2 |
p. e64-e65
nvt p.
|
artikel
|
| 12 |
Constitutive down-regulation of Osterix in osteoblasts from myeloma patients: In vitro effect of Bortezomib and Lenalidomide
|
De Matteo, Monica
|
|
2010
|
34 |
2 |
p. 243-249
7 p.
|
artikel
|
| 13 |
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes
|
Benetatos, Leonidas
|
|
2010
|
34 |
2 |
p. 148-153
6 p.
|
artikel
|
| 14 |
Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2
|
Chen, Szu-Ting
|
|
2010
|
34 |
2 |
p. 250-253
4 p.
|
artikel
|
| 15 |
Detection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell line
|
Chi, Hoang Thanh
|
|
2010
|
34 |
2 |
p. 261-262
2 p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
2010
|
34 |
2 |
p. CO2-
1 p.
|
artikel
|
| 17 |
Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism
|
Doudican, Nicole A.
|
|
2010
|
34 |
2 |
p. 229-234
6 p.
|
artikel
|
| 18 |
Epigenetic modifications in AML and MDS
|
Mahmud, Mohammad
|
|
2010
|
34 |
2 |
p. 139-140
2 p.
|
artikel
|
| 19 |
Flow cytometric detection of human telomerase reverse transcriptase (hTERT) expression in a subpopulation of bone marrow cells
|
Handa, Hiroshi
|
|
2010
|
34 |
2 |
p. 177-183
7 p.
|
artikel
|
| 20 |
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: An exceptionally rare observation
|
Ales, Micaela
|
|
2010
|
34 |
2 |
p. e58-e59
nvt p.
|
artikel
|
| 21 |
Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its derivative treatment
|
Chen, Feng
|
|
2010
|
34 |
2 |
p. e75-e77
nvt p.
|
artikel
|
| 22 |
Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study
|
Chun, Kathy
|
|
2010
|
34 |
2 |
p. 160-165
6 p.
|
artikel
|
| 23 |
Insights into Familial Platelet Disorder with Propensity to Myeloid Malignancy (FPD/AML)
|
Owen, Carolyn
|
|
2010
|
34 |
2 |
p. 141-142
2 p.
|
artikel
|
| 24 |
Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies
|
Warren, Madhuri
|
|
2010
|
34 |
2 |
p. 210-220
11 p.
|
artikel
|
| 25 |
Micafungin-induced hemolysis attack due to drug-dependent antibody persisting for more than 6 weeks
|
Yoshizawa, Seiichiro
|
|
2010
|
34 |
2 |
p. e60-e61
nvt p.
|
artikel
|
| 26 |
Motor disability in malignant hematology: An epidemiological study on Italian hospitalized patients
|
Tendas, Andrea
|
|
2010
|
34 |
2 |
p. e66-
1 p.
|
artikel
|
| 27 |
Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia
|
Breccia, Massimo
|
|
2010
|
34 |
2 |
p. 129-134
6 p.
|
artikel
|
| 28 |
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: Utility of fluorescence in situ hybridization (FISH) in a case–control study
|
Chang, Cindy M.
|
|
2010
|
34 |
2 |
p. 190-195
6 p.
|
artikel
|
| 29 |
Pain and emotional distress in leukemia patients at diagnosis
|
Morselli, Monica
|
|
2010
|
34 |
2 |
p. e67-e68
nvt p.
|
artikel
|
| 30 |
Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia
|
Hartman, A.
|
|
2010
|
34 |
2 |
p. 154-159
6 p.
|
artikel
|
| 31 |
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor
|
Tong, Wei-Gang
|
|
2010
|
34 |
2 |
p. 221-228
8 p.
|
artikel
|
| 32 |
Primary cutaneous anaplastic large-cell lymphoma presenting with hemophagocytic syndrome: A case report and review of the literature
|
Shimizu, Yoko
|
|
2010
|
34 |
2 |
p. 263-266
4 p.
|
artikel
|
| 33 |
Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) and JAK2V617F mutation transformed to acute myeloid leukaemia with chromosomal evolution including monosomy 7
|
Pich, Achille
|
|
2010
|
34 |
2 |
p. e69-e70
nvt p.
|
artikel
|
| 34 |
Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib
|
Breccia, Massimo
|
|
2010
|
34 |
2 |
p. 143-147
5 p.
|
artikel
|
| 35 |
Telomerase gene mutation screening in Chinese patients with aplastic anemia
|
Han, Bing
|
|
2010
|
34 |
2 |
p. 258-260
3 p.
|
artikel
|
| 36 |
The TCL1 mouse as a model for chronic lymphocytic leukemia
|
Hamblin, Terry J.
|
|
2010
|
34 |
2 |
p. 135-136
2 p.
|
artikel
|
| 37 |
TKIs and transplant for chronic myeloid leukemia
|
Litzow, Mark R.
|
|
2010
|
34 |
2 |
p. 137-138
2 p.
|
artikel
|
| 38 |
t(X;17) as the sole karyotypic anomaly in a case of M3r subtype of acute promyelocytic leukemia without RARα rearrangement
|
Wang, Huan-Ping
|
|
2010
|
34 |
2 |
p. e55-e57
nvt p.
|
artikel
|
| 39 |
Valproic acid exerts differential effects on CXCR4 expression in leukemic cells
|
Gul, Hilal
|
|
2010
|
34 |
2 |
p. 235-242
8 p.
|
artikel
|
Tijdschrift beschrijving